Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4796)
All Articles published online
|
Jan 7, 2008 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xiang JY, Ouyang Q, Li GD, Xiao NP. Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis. World J Gastroenterol 2008; 14(1): 53-57 [PMID: 18176961 DOI: 10.3748/wjg.14.53] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i1/53.htm |
| Number | Citing Articles |
| 1 |
Fang Chen, Yue Hu, Yi-Hong Fan, Bin Lv. Clinical Value of Fecal Calprotectin in Predicting Mucosal Healing in Patients With Ulcerative Colitis. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.679264
|
| 2 |
Mercedes Márquez, Clotilde Fernández Gutiérrez del Álamo, José Antonio Girón-González. Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity. World Journal of Gastroenterology 2016; 22(4): 1433-1448 doi: 10.3748/wjg.v22.i4.1433
|
| 3 |
Lirui Wang, Cristina Llorente, Phillipp Hartmann, An-Ming Yang, Peng Chen, Bernd Schnabl. Methods to determine intestinal permeability and bacterial translocation during liver disease. Journal of Immunological Methods 2015; 421: 44 doi: 10.1016/j.jim.2014.12.015
|
| 4 |
Susan Levenstein, Cosimo Prantera. Psychological Factors, Symptoms, and Mucosal Inflammation in Inflammatory Bowel Disease. American Journal of Gastroenterology 2016; 111(10): 1498 doi: 10.1038/ajg.2016.278
|
| 5 |
|
| 6 |
Martine De Vos, Edouard J. Louis, Jørgen Jahnsen, Jo G.P. Vandervoort, Maja Noman, Olivier Dewit, Geert R. DʼHaens, Denis Franchimont, Filip J. Baert, Roald A. Torp, Magne Henriksen, Philippe M.R. Potvin, Philippe P. Van Hootegem, Pieter M. Hindryckx, Tom G. Moreels, Arnaud Collard, Lars Normann Karlsen, Eirik Kittang, Guy Lambrecht, Tore Grimstad, Jonas Koch, Idar Lygren, Jean-Claude R.J. Coche, Fazia Mana, André Van Gossum, Jacques Belaiche, Mike R. Cool, Fernand Fontaine, Jean-Marc G. Maisin, Vinciane Muls, Bart Neuville, Dirk A. J. Staessen, Gert A. Van Assche, Thomas de Lange, Inger Camilla Solberg, Bert J.K. Vander Cruyssen, Severine A.R.A. Vermeire. Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy. Inflammatory Bowel Diseases 2013; 19(10): 2111 doi: 10.1097/MIB.0b013e31829b2a37
|
| 7 |
Ying Cui, Jun Zhang, Yan Chen, Le-gao Chen. Upregulation of Fecal Epithelial Heparanase mRNA Is Associated with Increased Ulcerative Colitis Activity and Cancerization Risk. Digestive Diseases and Sciences 2021; 66(5): 1488 doi: 10.1007/s10620-020-06350-y
|
| 8 |
H Cypers, G Varkas, S Beeckman, K Debusschere, T Vogl, J Roth, M B Drennan, M Lavric, D Foell, C A Cuvelier, M De Vos, J Delanghe, F Van den Bosch, D Elewaut. Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis. Annals of the Rheumatic Diseases 2016; 75(7): 1357 doi: 10.1136/annrheumdis-2015-208025
|
| 9 |
Dora Grgić, Karlo Golubić, Marko Brinar, Željko Krznarić. Predictive value of faecal calprotectin in ulcerative colitis – single centre experience. Annals of Medicine 2022; 54(1): 1570 doi: 10.1080/07853890.2022.2082518
|
| 10 |
Joseph Amara, Youakim Saliba, Joelle Hajal, Viviane Smayra, Jules-Joel Bakhos, Raymond Sayegh, Nassim Fares. Circadian Rhythm Disruption Aggravates DSS-Induced Colitis in Mice with Fecal Calprotectin as a Marker of Colitis Severity. Digestive Diseases and Sciences 2019; 64(11): 3122 doi: 10.1007/s10620-019-05675-7
|
| 11 |
Katarzyna Lewandowska, Olga Ciepiela. The correlation between the concentration of faecal calprotectin and markers of inflammation in children with gastrointestinal disorders. Diagnostyka Laboratoryjna 2017; 53(2): 91 doi: 10.5604/01.3001.0013.7968
|
| 12 |
Rayna Shentova, Mila Baycheva, Petio Hadjiiski, Denitza Kofinova, Penka Yaneva. Role of faecal calprotectin as a predictor of endoscopic activity in paediatric patients with ulcerative colitis. Gastroenterología y Hepatología (English Edition) 2020; 43(1): 57 doi: 10.1016/j.gastre.2019.08.005
|
| 13 |
Allison L. Goetsch, Dana Kimelman, Teresa K. Woodruff. Fertility Preservation and Restoration for Patients with Complex Medical Conditions. 2017; : 249 doi: 10.1007/978-3-319-52316-3_15
|
| 14 |
Kousaku Kawashima, Shunji Ishihara, Takafumi Yuki, Koji Onishi, Yoshinori Kushiyama, Hirofumi Fujishiro, Youichi Miyaoka, Mika Yuki, Yoshinori Komazawa, Takashi Tanimura, Hiroki Sonoyama, Yasumasa Tada, Ryusaku Kusunoki, Akihiko Oka, Nobuhiko Fukuba, Naoki Oshima, Ichiro Moriyama, Yoshikazu Kinoshita. Therapeutic Efficacy of pH-Dependent Release Formulation of Mesalazine on Active Ulcerative Colitis Resistant to Time-Dependent Release Formulation: Analysis of Fecal Calprotectin Concentration. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/342751
|
| 15 |
Cong Dai, Zi-Yuan Dong, Yi-Nuo Wang, Yu-Hong Huang, Min Jiang. Development and validation of a nomogram to predict Non-Response to 5-aminosalicylic acid in patients with ulcerative colitis. Revista Española de Enfermedades Digestivas 2023; doi: 10.17235/reed.2023.9703/2023
|
| 16 |
Hrishikesh Samant, Devendra Desai, Philip Abraham, Anand Joshi, Tarun Gupta, Alpa Dherai, Tester Ashavaid. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease. Indian Journal of Gastroenterology 2015; 34(6): 431 doi: 10.1007/s12664-015-0608-x
|
| 17 |
Hossam M. Elsaadany, Mohammed F. Almaghraby, Awatif A. Edrees, Yasser M. Elsherbiny, Roobina K. Kumar. Utility of fecal calprotectin as a discriminative biomarker between ulcerative colitis and irritable bowel syndrome and its ability to be used for the assessment of the remission stage of ulcerative colitis. The Egyptian Journal of Internal Medicine 2016; 28(1): 21 doi: 10.4103/1110-7782.182956
|
| 18 |
Nages Nagaratnam, Kujan Nagaratnam, Gary Cheuk. Geriatric Diseases. 2018; : 153 doi: 10.1007/978-3-319-33434-9_16
|
| 19 |
Dae Bum Kim, Kang-Moon Lee, Ji Min Lee, Yoon Yung Chung, Hea Jung Sung, Chang Nyol Paik, Woo Chul Chung, Ji-Han Jung, Hyun Joo Choi. Correlation between Histological Activity and Endoscopic, Clinical, and Serologic Activities in Patients with Ulcerative Colitis. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/5832051
|
| 20 |
Ryosuke Horio, Jun Kato, Yuki Ohta, Takashi Taida, Keiko Saito, Miyuki Iwasaki, Yusuke Ozeki, Yushi Koshibu, Nobuaki Shu, Makoto Furuya, Yuhei Oyama, Hayato Nakazawa, Yukiyo Mamiya, Chihiro Goto, Satsuki Takahashi, Akane Kurosugi, Michiko Sonoda, Tatsuya Kaneko, Naoki Akizue, Kenichiro Okimoto, Tomoaki Matsumura, Naoya Kato. Risk factors for clinical relapse in patients with ulcerative colitis who are in clinical remission but with endoscopic activity. JGH Open 2024; 8(7) doi: 10.1002/jgh3.70011
|
| 21 |
Rayna Shentova, Mila Baycheva, Petio Hadjiiski, Denitza Kofinova, Penka Yaneva. Role of faecal calprotectin as a predictor of endoscopic activity in paediatric patients with ulcerative colitis. Gastroenterología y Hepatología 2020; 43(1): 57 doi: 10.1016/j.gastrohep.2019.08.011
|
| 22 |
Eun Hye Lee, Jae Sung Ko, Jeong Kee Seo. Correlations of Plasma Citrulline Levels With Clinical and Endoscopic Score and Blood Markers According to Small Bowel Involvement in Pediatric Crohn Disease. Journal of Pediatric Gastroenterology and Nutrition 2013; 57(5): 570 doi: 10.1097/MPG.0b013e31829e264e
|
| 23 |
Francisco Rodríguez-Moranta, Triana Lobatón, Lorena Rodríguez-Alonso, Jordi Guardiola. Calprotectina fecal en el diagnóstico de enfermedades inflamatorias. Gastroenterología y Hepatología 2013; 36(6): 400 doi: 10.1016/j.gastrohep.2012.10.008
|
| 24 |
Serkan Torun, Bilge Demirel Tunc, Burak Suvak, Hakan Yildiz, Adnan Tas, Abdurrahim Sayilir, Yasemin Ozin Ozderin, Yavuz Beyazit, Ertugrul Kayacetin. Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: A promising marker in predicting disease severity. Clinics and Research in Hepatology and Gastroenterology 2012; 36(5): 491 doi: 10.1016/j.clinre.2012.06.004
|
| 25 |
Bruno Lima Rodrigues, Márcia Carolina Mazzaro, Cristiane Kibune Nagasako, Maria de Lourdes Setsuko Ayrizono, João José Fagundes, Raquel Franco Leal. Assessment of disease activity in inflammatory bowel diseases: Non-invasive biomarkers and endoscopic scores. World Journal of Gastrointestinal Endoscopy 2020; 12(12): 504-520 doi: 10.4253/wjge.v12.i12.504
|
| 26 |
Anne-Claire Frin, Jérôme Filippi, Gilles Boschetti, Bernard Flourie, Jocelyne Drai, Patricia Ferrari, Xavier Hebuterne, Stéphane Nancey. Accuracies of fecal calprotectin, lactoferrin, M2-pyruvate kinase, neopterin and zonulin to predict the response to infliximab in ulcerative colitis. Digestive and Liver Disease 2017; 49(1): 11 doi: 10.1016/j.dld.2016.09.001
|
| 27 |
Jost Langhorst, James Boone, Romy Lauche, Andreas Rueffer, Gustav Dobos. Faecal Lactoferrin, Calprotectin, PMN-elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial. Journal of Crohn's and Colitis 2016; 10(7): 786 doi: 10.1093/ecco-jcc/jjw044
|
| 28 |
Yang Woon Lee, Kang-Moon Lee, Ji Min Lee, Yoon Yung Chung, Dae Bum Kim, Yeon Ji Kim, Woo Chul Chung, Chang-Nyol Paik. The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity. The Korean Journal of Internal Medicine 2019; 34(1): 72 doi: 10.3904/kjim.2016.324
|
| 29 |
Nages Nagaratnam, Kujan Nagaratnam, Gary Cheuk. Geriatric Diseases. 2017; : 1 doi: 10.1007/978-3-319-32700-6_16-1
|
| 30 |
Qian Guo, Xicao Zha, Chun Li, Yuan Jia, Lei Zhu, Jianping Guo, Yin Su. Serum calprotectin—a promising diagnostic marker for adult-onset Still’s disease. Clinical Rheumatology 2016; 35(1): 73 doi: 10.1007/s10067-015-3108-6
|
| 31 |
Giulia Roda, Alessandra Caponi, Marco Benevento, Paolo Nanni, Laura Mezzanotte, Andrea Belluzzi, Lloyd Mayer, Aldo Roda. New proteomic approaches for biomarker discovery in inflammatory bowel disease. Inflammatory Bowel Diseases 2010; 16(7): 1239 doi: 10.1002/ibd.21212
|
| 32 |
Saranya Sasidharan, Alexa N Sasson, Kevin M Shannon, Ashwin N Ananthakrishnan. Fecal Calprotectin Is a Predictor of Need for Rescue Therapy in Hospitalized Severe Colitis. Inflammatory Bowel Diseases 2022; 28(12): 1833 doi: 10.1093/ibd/izac011
|
| 33 |
|
| 34 |
Harland S. Winter, Piotr Krzeski, Melvin B. Heyman, Eduardo Ibarguen‐Secchia, Barbara Iwanczak, Maciej Kaczmarski, Jaroslaw Kierkus, Sanja Kolaček, Bankole Osuntokun, J. Antonio Quiros, Manoj Shah, Bruce Yacyshyn, Preston M. Dunnmon. High‐ and Low‐Dose Oral Delayed‐Release Mesalamine in Children With Mild‐to‐Moderately Active Ulcerative Colitis. Journal of Pediatric Gastroenterology and Nutrition 2014; 59(6): 767 doi: 10.1097/MPG.0000000000000530
|
| 35 |
Athanasios Kostas, Spyros I Siakavellas, Charalambos Kosmidis, Anna Takou, Joanna Nikou, Georgios Maropoulos, John Vlachogiannakos, George V Papatheodoridis, Ioannis Papaconstantinou, Giorgos Bamias. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease. World Journal of Gastroenterology 2017; 23(41): 7387-7396 doi: 10.3748/wjg.v23.i41.7387
|
| 36 |
Sofija I. Lugonja, Ivana L. Pantic, Tamara M. Milovanovic, Vesna M. Grbovic, Bojana M. Djokovic, Željko D. Todorovic, Stefan M. Simovic, Raša H. Medovic, Nebojsa D. Zdravkovic, Natasa D. Zdravkovic. Atherosclerotic Cardiovascular Disease in Inflammatory Bowel Disease: The Role of Chronic Inflammation and Platelet Aggregation. Medicina 2023; 59(3): 554 doi: 10.3390/medicina59030554
|
| 37 |
Aranzazu Jauregui-Amezaga, María López-Cerón, Montserrat Aceituno, Mireya Jimeno, Cristina Rodríguez de Miguel, Susana Pinó-Donnay, Michel Zabalza, Miquel Sans, Elena Ricart, Ingrid Ordás, Begoña González-Suárez, Miriam Cuatrecasas, Josep Llach, Julian Panés, María Pellise. Accuracy of Advanced Endoscopy and Fecal Calprotectin for Prediction of Relapse in Ulcerative Colitis. Inflammatory Bowel Diseases 2014; 20(7): 1187 doi: 10.1097/MIB.0000000000000069
|
| 38 |
Sayaka Yamaguchi, Yoshiaki Takeuchi, Katsuhito Arai, Katsuyuki Fukuda, Yuichiro Kuroki, Kunio Asonuma, Hiroshi Takahashi, Masayuki Saruta, Hitoshi Yoshida. Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis. Journal of Gastroenterology and Hepatology 2016; 31(1): 93 doi: 10.1111/jgh.13061
|
| 39 |
Danusia Onişor, Alina Boeriu, Ofelia Pascarenco, Olga Brusnic, Daniela Dobru. Role of fecal calprotectin as a biomarker of intestinal inflammation in ulcerative colitis: a prospective study. Revista Romana de Medicina de Laborator 2018; 26(3): 335 doi: 10.2478/rrlm-2018-0006
|
| 40 |
Shapur Ikhtaire, Mohammad Sharif Shajib, Walter Reinisch, Waliul Islam Khan. Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease. Journal of Gastroenterology 2016; 51(5): 434 doi: 10.1007/s00535-016-1182-4
|
| 41 |
Tawfik El-Raouf. Long Pentraxin PTX 3 and Faecal Calprotectin as a Non Invasive Biomarkers for Ulcerative Colitis. Archives of Clinical Gastroenterology 2017; : 011 doi: 10.17352/2455-2283.000030
|
| 42 |
Hassan Vosoughinia, Maryam Latifnia, Mojtaba Fattahi Abdizadeh, Elham Mokhtari Amirmajdi, Mitra Ahadi. The Relation Between Fecal Calprotectin and the Rate of Clinical Activity of Ulcerative Colitis. Razavi International Journal of Medicine 2018; 6(1) doi: 10.5812/rijm.14533
|
| 43 |
Maria Gloria Mumolo, Lorenzo Bertani, Linda Ceccarelli, Gabriella Laino, Giorgia Di Fluri, Eleonora Albano, Gherardo Tapete, Francesco Costa. From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting. World Journal of Gastroenterology 2018; 24(33): 3681-3694 doi: 10.3748/wjg.v24.i33.3681
|
| 44 |
Arafat Kassem, Hosam A.S. Shabana, Mabrouk M. Aboelenin. Comparative study the levels of plasma transforming growth factor-β1, serum crp, fecal lactoferrin, and fecal calprotectin as biomarkers for disease activity in Egyptian patients with ulcerative colitis. The Scientific Journal of Al-Azhar Medical Faculty, Girls 2019; 3(1): 79 doi: 10.4103/sjamf.sjamf_58_18
|
| 45 |
Dan Turner, Cynthia H. Seow, Gordon R. Greenberg, Anne M. Griffiths, Mark S. Silverberg, A. Hillary Steinhart. A Systematic Prospective Comparison of Noninvasive Disease Activity Indices in Ulcerative Colitis. Clinical Gastroenterology and Hepatology 2009; 7(10): 1081 doi: 10.1016/j.cgh.2009.06.024
|
| 46 |
Tarang Taghvaei, Iradj Maleki, Farshad Nagshvar, Hafez Fakheri, Vahid Hosseini, Seyed Mohammad Valizadeh, Hassan Neishaboori. Fecal calprotectin and ulcerative colitis endoscopic activity index as indicators of mucosal healing in ulcerative colitis. Internal and Emergency Medicine 2015; 10(3): 321 doi: 10.1007/s11739-014-1144-x
|
| 47 |
Lorenzo Bertani, Maria Gloria Mumolo, Gherardo Tapete, Eleonora Albano, Giovanni Baiano Svizzero, Federico Zanzi, Linda Ceccarelli, Massimo Bellini, Santino Marchi, Francesco Costa. Fecal calprotectin: current and future perspectives for inflammatory bowel disease treatment. European Journal of Gastroenterology & Hepatology 2020; 32(9): 1091 doi: 10.1097/MEG.0000000000001731
|
| 48 |
Ali Ghweil, Ashraf Khodeary, Shereen Philip Aziz. Diagnostic Value of Fecal Calprotectin and Serum MMP-9 in Diagnosing Disease Activity of Ulcerative Colitis. Open Journal of Gastroenterology 2018; 8(06): 234 doi: 10.4236/ojgas.2018.86026
|
| 49 |
Bincy P. Abraham, Selvi Thirumurthi. Clinical significance of inflammatory markers. Current Gastroenterology Reports 2009; 11(5): 360 doi: 10.1007/s11894-009-0055-x
|
| 50 |
Rachele Ciccocioppo, Venerina Imbesi, Elena Betti, Vincenzo Boccaccio, Peter Kruzliak, Alessandra Gallia, Giuseppina Cristina Cangemi, Gabriella Carnevale Maffe, Alessandro Vanoli, Serena Merante, Mara De Amici, Colomba Falcone, Catherine Klersy, Gino Roberto Corazza. The Circulating Level of Soluble Receptor for Advanced Glycation End Products Displays Different Patterns in Ulcerative Colitis and Crohn’s Disease: A Cross-Sectional Study. Digestive Diseases and Sciences 2015; 60(8): 2327 doi: 10.1007/s10620-015-3619-7
|
| 51 |
Dan Turner, Frank M. Ruemmele, Esther Orlanski‐Meyer, Anne M. Griffiths, Javier Martin de Carpi, Jiri Bronsky, Gabor Veres, Marina Aloi, Caterina Strisciuglio, Christian P. Braegger, Amit Assa, Claudio Romano, Séamus Hussey, Michael Stanton, Mikko Pakarinen, Lissy de Ridder, Konstantinos Katsanos, Nick Croft, Victor Navas‐López, David C. Wilson, Sally Lawrence, Richard K. Russell. Management of Paediatric Ulcerative Colitis, Part 1. Journal of Pediatric Gastroenterology and Nutrition 2018; 67(2): 257 doi: 10.1097/MPG.0000000000002035
|
| 52 |
Miguel Regueiro, Joseph Rodemann, Kevin E. Kip, Melissa Saul, Jason Swoger, Leonard Baidoo, Marc Schwartz, Arthur Barrie, David Binion. Physician assessment of ulcerative colitis activity correlates poorly with endoscopic disease activity. Inflammatory Bowel Diseases 2011; 17(4): 1008 doi: 10.1002/ibd.21445
|
| 53 |
Henrike M. Hamer, Daisy M.A.E. Jonkers, Steven A.L.W. Vanhoutvin, Freddy J. Troost, Ger Rijkers, Adriaan de Bruïne, Aalt Bast, Koen Venema, Robert-Jan M. Brummer. Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission. Clinical Nutrition 2010; 29(6): 738 doi: 10.1016/j.clnu.2010.04.002
|
| 54 |
Liang Zhang, Craig D. Wallace, Jamie E. Erickson, Christine M. Nelson, Stephanie M. Gaudette, Calvin S. Pohl, Samuel D. Karsen, Gricelda H. Simler, Ruoqi Peng, Christopher A. Stedman, F. Stephen Laroux, Marc A. Wurbel, Rajesh V. Kamath, Bradford L. McRae, Annette J. Schwartz Sterman, Soumya Mitra. Near infrared readouts offer sensitive and rapid assessments of intestinal permeability and disease severity in inflammatory bowel disease models. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-61756-y
|
| 55 |
Gabriela Maria Henz Giovelli, Ornella Sari Cassol, Marcio Lubini, Angelina Dantas Costa, Édina Gaviraghi, Laura de Cezaro Martini. Evaluation of Proactive Therapeutic Drug Monitoring Application in Infliximab Users in Ulcerative Colitis. Journal of Coloproctology 2023; 43(04): e286 doi: 10.1055/s-0043-1776889
|
| 56 |
Anna Luisa Bathe, Eirini Mavropoulou, Nicolae-Catalin Mechie, Golo Petzold, Volker Ellenrieder, Steffen Kunsch, Ahmad Amanzada, Bruno Bonaz. Impact of faecal calprotectin measurement on clinical decision-making in patients with Crohn’s disease and ulcerative colitis. PLOS ONE 2019; 14(10): e0223893 doi: 10.1371/journal.pone.0223893
|
| 57 |
Michelle Vu, Daniel W. Hommes. Medical Therapy of Ulcerative Colitis. 2014; : 457 doi: 10.1007/978-1-4939-1677-1_42
|
| 58 |
Cansel Turkay, Benan Kasapoglu. Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update. Clinics 2010; 65(2): 221 doi: 10.1590/S1807-59322010000200015
|
| 59 |
Marco Daperno, Fabiana Castiglione, Lissy de Ridder, Iris Dotan, Martti Färkkilä, Jon Florholmen, Gerald Fraser, Walter Fries, Xavier Hebuterne, Peter Laszlo Lakatos, Julián Panés, Jordi Rimola, Edouard Louis. Results of the 2nd part Scientific Workshop of the ECCO (II): Measures and markers of prediction to achieve, detect, and monitor intestinal healing in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2011; 5(5): 484 doi: 10.1016/j.crohns.2011.07.003
|
| 60 |
Gerda C Leitner, Harald Vogelsang. Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults. World Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(1): 5-20 doi: 10.4292/wjgpt.v7.i1.5
|
| 61 |
Anastassios C. Manolakis, Andreas N. Kapsoritakis, Elisavet K. Tiaka, Spyros P. Potamianos. Calprotectin, Calgranulin C, and Other Members of the S100 Protein Family in Inflammatory Bowel Disease. Digestive Diseases and Sciences 2011; 56(6): 1601 doi: 10.1007/s10620-010-1494-9
|
| 62 |
Wei-Chen Lin, Jau-Min Wong, Chien-Chih Tung, Ching-Pin Lin, Jen-Wei Chou, Horng-Yuan Wang, Ming-Jium Shieh, Chin-Hao Chang, Heng-Hsiu Liu, Shu-Chen Wei, Taiwan Society of Inflammatory Bowel Disease Multicenter Study. Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients. World Journal of Gastroenterology 2015; 21(48): 13566-13573 doi: 10.3748/wjg.v21.i48.13566
|
| 63 |
Yoshiki Matsuda, Nobuyuki Ozawa, Takiko Shinozaki, Ken-ichi Wakabayashi, Kosuke Suzuki, Yusuke Kawano, Iwao Ohtsu, Yoshitaka Tatebayashi. Ergothioneine, a metabolite of the gut bacterium Lactobacillus reuteri, protects against stress-induced sleep disturbances. Translational Psychiatry 2020; 10(1) doi: 10.1038/s41398-020-0855-1
|
| 64 |
SANG-YOUN JUNG, YONG-BEOM PARK, YOU-JUNG HA, KWANG-HOON LEE, SOO-KON LEE. Serum Calprotectin as a Marker for Disease Activity and Severity in Adult-onset Still’s Disease. The Journal of Rheumatology 2010; 37(5): 1029 doi: 10.3899/jrheum.091120
|
| 65 |
Sun-Ho Lee, Min-Ju Kim, Kiju Chang, Eun Mi Song, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis. BMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-017-0669-7
|
| 66 |
Bincy P. Abraham, Sunanda Kane. Fecal Markers: Calprotectin and Lactoferrin. Gastroenterology Clinics of North America 2012; 41(2): 483 doi: 10.1016/j.gtc.2012.01.007
|
| 67 |
Shunsuke Sekiya, Makoto Murata, Satoshi Arai, Hiroshi Murayama, Atushi Kawasaki, Noriyuki Ashida, Kohki Okada, Masaki Ikemoto. Enzyme-linked immunosorbent assay for S100A9 in the stool of rats with dextran sulfate sodium-induced colitis. Journal of Immunological Methods 2016; 439: 44 doi: 10.1016/j.jim.2016.09.009
|
| 68 |
Rayna Shentova-Eneva, Tsvetelina Velikova. Laboratory Assessment of Disease Activity in Pediatric Patients with Inflammatory Bowel Disease: What’s New?. Gastroenterology Insights 2020; 11(2): 58 doi: 10.3390/gastroent11020009
|
| 69 |
O. A. El-Kawy, M. H. Sanad, F. Marzook. 99mTc-Mesalamine as potential agent for diagnosis and monitoring of ulcerative colitis: labelling, characterisation and biological evaluation. Journal of Radioanalytical and Nuclear Chemistry 2016; 308(1): 279 doi: 10.1007/s10967-015-4338-4
|
| 70 |
Almina Jukic, Latifa Bakiri, Erwin F. Wagner, Herbert Tilg, Timon E. Adolph. Calprotectin: from biomarker to biological function. Gut 2021; 70(10): 1978 doi: 10.1136/gutjnl-2021-324855
|
| 71 |
Ashish Kumar Jha, Madhur Chaudhary, Vishwa Mohan Dayal, Amarendra Kumar, Sanjeev Kumar Jha, Praveen Jha, Shubham Purkayastha, Ravish Ranjan. Optimal cut‐off value of fecal calprotectin for the evaluation of ulcerative colitis: An unsolved issue?. JGH Open 2018; 2(5): 207 doi: 10.1002/jgh3.12074
|
| 72 |
Shimaa El Sharawy, Hemat El-Horany, Ibrahim Amer. Corrected ESR/Albumin Ratio as a Simple, Practical Marker Predicts the Severity in Egyptian Ulcerative Colitis Patients. The Open Biomarkers Journal 2021; 11(1): 8 doi: 10.2174/1875318302111010008
|
| 73 |
Marianne Guirgis, Emily Wendt, Lai Mun Wang, Alissa Walsh, Daniel Burger, Robert V. Bryant, Alex Kent, Rebecca Adamson, Oliver Brain, Simon P. L. Travis, Satish Keshav. Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative Colitis. Journal of Crohn's and Colitis 2016; : jjw174 doi: 10.1093/ecco-jcc/jjw174
|
| 74 |
A. C. Ouwehand, S. J. M. ten Bruggencate, A. J. Schonewille, E. Alhoniemi, S. D. Forssten, I. M. J. Bovee-Oudenhoven. Lactobacillus acidophilussupplementation in human subjects and their resistance to enterotoxigenicEscherichia coliinfection. British Journal of Nutrition 2014; 111(3): 465 doi: 10.1017/S0007114513002547
|
| 75 |
Dan Turner, David R. Mack, Jeffrey Hyams, Neal LeLeiko, Anthony Otley, James Markowitz, Yair Kasirer, Aleixo Muise, Cynthia H. Seow, Mark S. Silverberg, Wallace Crandall, Anne M. Griffiths. C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis. Journal of Crohn's and Colitis 2011; 5(5): 423 doi: 10.1016/j.crohns.2011.05.003
|
| 76 |
Triana Lobatón, Francisco Rodríguez-Moranta, Alicia Lopez, Elena Sánchez, Lorena Rodríguez-Alonso, Jordi Guardiola. A New Rapid Quantitative Test for Fecal Calprotectin Predicts Endoscopic Activity in Ulcerative Colitis. Inflammatory Bowel Diseases 2013; 19(5): 1034 doi: 10.1097/MIB.0b013e3182802b6e
|